equine polyclonal antibody therapy (Vical/AnGes)

N/A

Report date: 2025/01/26 17:58:57

Base Information

Drug Nameequine polyclonal antibody therapy (Vical/AnGes)
Drug Alias Namepolyclonal antibody therapy (Vical/AnGes)equine polyclonal antibody therapy(Fresh Tracks Therapeutics/AnGes)equine polyclonal antibody therapy (Brickell Biotech/AnGes)
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineBiologics > Protein drugs > Immunoglobulin > Antibody > Polyclonal antibodies
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHemorrhagic Fever, Ebola
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFresh Tracks Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesFresh Tracks Therapeutics IncAnges Inc
Inactive CompaniesN/A
Active IndicationsHemorrhagic Fever, Ebola
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A